Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- White Paper Focuses on Different Economic Conditions between Generations
September 23, 2002
- Ortho Clinical Diagnostics: HCV Antigen Test Kits
September 23, 2002
- NEW PRODUCTS
September 23, 2002
- Gastric Cancer Discovered in 0.29% of Individuals by Endoscopy
September 23, 2002
- Specialization in Niche Market Recommended for Japanese Companies: Dr Bouee
September 23, 2002
- Toshiba: New Biochemical Analyzer ARCHITECT c8000
September 23, 2002
- BUSINESS NEWS IN BRIEF
September 23, 2002
- Takeda to Market Environmental Pollution Reagents via Biosense of Norway
September 23, 2002
- Female MRs Increasing: Education Center Report
September 23, 2002
- Kurabo Ties Up with Agilent Technologies for Contract Gene Analysis
September 23, 2002
- Generic Manufacturers Face Problems with Distribution
September 23, 2002
- Need for Spreading CAPD Stressed: Terumo Seminar
September 23, 2002
- Overseas Clinical Trials of Ono's Elaspol Suspended
September 23, 2002
- OTC NEWS IN BRIEF
September 23, 2002
- Daiichi to Restructure Global R&D System
September 23, 2002
- PRESS SEMINAR
September 23, 2002
- Taisho Toyama Pharm to Be Created Next Month
September 23, 2002
- Orthopaedic Associations Launch Campaign to Prevent Fractures
September 23, 2002
- Initial Sales of Bisphosphonate Disappointing
September 23, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 23, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…